City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation

Border Border
The following is a list of available studies directed by  Nayana Vora, MD  
Search results:  2  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-2 Trials Jump to page:

COH Protocol Number: 13376 Number: NCT01385748

Principal Investigator: Nayana Vora, MD
Sponsor: Industrial

Title:  A Phase II, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Clonidine Lauriad 50ug and 100ug Mucoadhesive Buccal Tablet (MBT) Applied Once Daily to those of Placebo in the Prevention and Treatment of Chemoradiation Therapy Induced Oral Mucositis in Patients with Head and Neck Cancer

COH Protocol Number: 11104 Number: NCT01349322

Principal Investigator: Nayana Vora, MD
Sponsor: Cooperative Group

Title:  RTOG 1005: A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus Sequential Boost for Early-Stage Breast Cancer

Results per page: 25 50 100 All 1-2 Trials Jump to page:

NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.